ASD vs. CNCR

Last updated Jul 1, 2026

ASD (Defiance Autism Impact ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. Both charge a 0.79% expense ratio.

Performance

ASD vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Autism Impact ETF (ASD) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ASD

• 1D: 0.51%
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASD vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
ASD Defiance Autism Impact ETF	9.64%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

Return for Risk

ASD vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Autism Impact ETF (ASD) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

ASD vs. CNCR - Drawdown Comparison

The maximum ASD drawdown since its inception was -2.42%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ASD and CNCR.

Drawdown Indicators

	ASD	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-2.42%	0.00%	-2.42%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-0.78%	0.00%	-0.78%

Volatility

Volatility by Period

	ASD	CNCR	Difference
Volatility (1Y) Calculated over the trailing 1-year period	17.25%	0.00%	+17.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.25%	0.00%	+17.25%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.25%	0.00%	+17.25%

ASD vs. CNCR - Expense Ratio Comparison

Both ASD and CNCR have an expense ratio of 0.79%.

Dividends

ASD vs. CNCR - Dividend Comparison

ASD's dividend yield for the trailing twelve months is around 0.02%, while CNCR has not paid dividends to shareholders.

Position	TTM
ASD Defiance Autism Impact ETF	0.02%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

Frequently Asked Questions

Which ETF is better, ASD or CNCR?

Both ETFs have the same 0.79% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, ASD or CNCR?

ASD and CNCR have the same expense ratio: 0.79% per year.

Which ETF pays a higher dividend yield, ASD or CNCR?

ASD has the higher dividend yield at 0.02%, compared with 0.00% for CNCR.

What is the main difference between ASD and CNCR?

They also come from different issuers: Defiance and Exchange Traded Concepts.